The $13 Million Company Teaching the Immune System to Hunt Cancer
May 29, 2026
Cannabics Pharmaceuticals’ Drug Candidate Exhibits 30% Tumor Volume Reduction in Mice
June 28, 2021
Related Post
-
-
BioLineRx Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 27, 2026
-
HCW Biologics Exercised Option to Regain Full Rights for Two Commercial-Ready Reagents from Wugen
May 27, 2026
-
Hoth Therapeutics Becomes Rocket One Inc. (Nasdaq: RKTO), Targeting the Space Economy with Next-Generation Nanomagnetic AI Chip Technology and Ultra-Low-Power, Radiation-Tolerant Computing for Space and Defense Applications
May 27, 2026